Validated Alzheimer's Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s

dc.contributor.authorCherbuin, Nicolas
dc.contributor.authorShaw, Marnie
dc.contributor.authorWalsh, Erin
dc.contributor.authorSachdev, Perminder Singh
dc.contributor.authorAnstey, Kaarin
dc.date.accessioned2022-02-04T01:15:29Z
dc.date.available2022-02-04T01:15:29Z
dc.date.issued2019
dc.date.updated2020-12-13T07:20:04Z
dc.description.abstractStrong evidence is available suggesting that effective reduction of exposure to demonstrated modifiable risk factors in mid-life or before could significantly decrease the incidence of Alzheimer's disease (AD) and delay its onset. A key ingredient to achieving this goal is the reliable identification of individuals at risk well before they develop clinical symptoms. The aim of this study was to provide further neuroimaging evidence of the effectiveness of a validated tool, the ANU Alzheimer's Disease Risk Index, for the assessment of future risk of cognitive decline. Participants were 461 (60-64 years, 48% female) community-living individuals free of dementia at baseline. Associations between risk estimates obtained with the ANU-ADRI, total and regional brain volumes including in the default mode network (DMN) measured at the same assessment and diagnosis of MCI/dementia over a 12-year follow-up were tested in a large sample of community-living individuals free of dementia at baseline. Higher risk estimates on the ANU-ADRI were associated with lower cortical gray matter and particularly in the DMN. Importantly, difference in participants with high and low risk scores explained 7% of the observed difference in gray matter volume. In this sample, every one additional risk point on the ANU-ADRI was associated with an 8% increased risk of developing MCI/dementia over a 12-year follow-up and this association was partly mediated by a sub-region of the DMN. Risk of cognitive decline assessed with a validated instrument is associated with gray matter volume, particularly in the DMN, a region known to be implicated in the pathological process of the disease.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1931-7557en_AU
dc.identifier.urihttp://hdl.handle.net/1885/259065
dc.language.isoen_AUen_AU
dc.provenanceThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en_AU
dc.publisherSpringeren_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/973302en_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/179805en_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/157125en_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/1063907en_AU
dc.relationhttp://purl.org/au-research/grants/arc/FT120100227en_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/1002560en_AU
dc.rights© The Author(s) 2017. This article is an open access publicationen_AU
dc.rights.licenseCreative Commons Attribution 4.0 International Licenseen_AU
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_AU
dc.sourceBrain Imaging and Behavioren_AU
dc.subjectDementia risken_AU
dc.subjectANU-ADRIen_AU
dc.subjectDMNen_AU
dc.subjectMRIen_AU
dc.subjectMCIen_AU
dc.titleValidated Alzheimer's Disease Risk Index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60sen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue1en_AU
local.bibliographicCitation.lastpage74en_AU
local.bibliographicCitation.startpage65en_AU
local.contributor.affiliationCherbuin, Nicolas, College of Health and Medicine, ANUen_AU
local.contributor.affiliationShaw, Marnie, College of Engineering and Computer Science, ANUen_AU
local.contributor.affiliationWalsh, Erin, College of Health and Medicine, ANUen_AU
local.contributor.affiliationSachdev, Perminder Singh, University of New South Walesen_AU
local.contributor.affiliationAnstey, Kaarin, College of Health and Medicine, ANUen_AU
local.contributor.authoruidCherbuin, Nicolas, u3184049en_AU
local.contributor.authoruidShaw, Marnie, u3627775en_AU
local.contributor.authoruidWalsh, Erin, u4402564en_AU
local.contributor.authoruidAnstey, Kaarin, u4038535en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor111702 - Aged Health Careen_AU
local.identifier.absseo920502 - Health Related to Ageingen_AU
local.identifier.ariespublicationa383154xPUB9856en_AU
local.identifier.citationvolume13en_AU
local.identifier.doi10.1007/s11682-017-9789-5en_AU
local.identifier.scopusID2-s2.0-85038113206
local.publisher.urlhttps://link.springer.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Cherbuin_Validated_Alzheimer%27s_Disease_2017.pdf
Size:
1.11 MB
Format:
Adobe Portable Document Format